These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23459241)

  • 21. Novel therapeutic targets in diabetic macular edema: Beyond VEGF.
    Urias EA; Urias GA; Monickaraj F; McGuire P; Das A
    Vision Res; 2017 Oct; 139():221-227. PubMed ID: 28993218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing diabetic macular edema: The leading cause of diabetes blindness.
    Romero-Aroca P
    World J Diabetes; 2011 Jun; 2(6):98-104. PubMed ID: 21860693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticosteroid use for diabetic macular edema: old fad or new trend?
    Stewart MW
    Curr Diab Rep; 2012 Aug; 12(4):364-75. PubMed ID: 22581206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of diabetic retinopathy: Recent advances and unresolved challenges.
    Stewart MW
    World J Diabetes; 2016 Aug; 7(16):333-41. PubMed ID: 27625747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic Macular Edema: State of Art and Intraocular Pharmacological Approaches.
    Gurreri A; Pazzaglia A
    Adv Exp Med Biol; 2021; 1307():375-389. PubMed ID: 32488606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current trends in the pharmacotherapy of diabetic retinopathy.
    Kumar B; Gupta SK; Saxena R; Srivastava S
    J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy.
    Simó R; Sundstrom JM; Antonetti DA
    Diabetes Care; 2014 Apr; 37(4):893-9. PubMed ID: 24652720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
    Emerson MV; Lauer AK
    BioDrugs; 2007; 21(4):245-57. PubMed ID: 17628122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetic macular edema in Japan: a review and expert opinion.
    Terasaki H; Ogura Y; Kitano S; Sakamoto T; Murata T; Hirakata A; Ishibashi T
    Jpn J Ophthalmol; 2018 Jan; 62(1):1-23. PubMed ID: 29210010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
    Berrocal MH; Acaba LA; Chenworth ML
    Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema.
    Gonzalez-Cortes JH; Martinez-Pacheco VA; Gonzalez-Cantu JE; Bilgic A; de Ribot FM; Sudhalkar A; Mohamed-Hamsho J; Kodjikian L; Mathis T
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Intravitreal Anti-Vascular Growth Factor Agents With or Without Macular Photocoagulation on Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
    Cui L; Jiao B; Han Q
    Diabetes Ther; 2019 Aug; 10(4):1283-1296. PubMed ID: 31079358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.
    Dhoot DS; Avery RL
    Curr Diab Rep; 2016 Dec; 16(12):122. PubMed ID: 27766582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [TREATMENT OPTIONS FOR DIABETIC MACULAR EDEMA].
    Berco E; Rappoport D; Pollack A
    Harefuah; 2017 Feb; 156(2):109-113. PubMed ID: 28551902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for anti-VEGF treatment of diabetic macular edema.
    Bandello F; Berchicci L; La Spina C; Battaglia Parodi M; Iacono P
    Ophthalmic Res; 2012; 48 Suppl 1():16-20. PubMed ID: 22907145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Early Treatment Diabetic Retinopathy Study historical review and relevance to today's management of diabetic macular edema.
    Relhan N; Flynn HW
    Curr Opin Ophthalmol; 2017 May; 28(3):205-212. PubMed ID: 28151747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Real life retrospective study of 98 eyes treated with intravitreal dexamethasone or anti-VEGF injections for macular edema due to diabetes or retinal vein occlusion].
    Routier M; Ducloyer JB; Masse H; Lebreton O; Fossum P; Clement M; Weber M
    J Fr Ophtalmol; 2021 Oct; 44(8):1148-1158. PubMed ID: 34353656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranibizumab in the Treatment of Diabetic Macular Edema: A Review of the Current Status, Unmet Needs, and Emerging Challenges.
    Dervenis N; Mikropoulou AM; Tranos P; Dervenis P
    Adv Ther; 2017 Jun; 34(6):1270-1282. PubMed ID: 28484955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Diabetic Macular Edema.
    Kim EJ; Lin WV; Rodriguez SM; Chen A; Loya A; Weng CY
    Curr Diab Rep; 2019 Jul; 19(9):68. PubMed ID: 31359157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.